Having identified an oligonucleotide (ON) receptor in the HepG2 cell line, we have re-examined here the kinetics of ON uptake, subcellular distribution and intracellular localisation in these cells, at concentrations relevant for the study of a receptor-dependent process. Kinetic parameters of ON endocytosis were comparable with those of the receptor-mediated endocytosis tracer, transferrin (uptake equilibrium, saturation with concentration, specific competition and rapid efflux) and were clearly distinct from those of fluid-phase endocytosis. By analytical subcellular fractionation, particulate ON showed a bimodal distribution after 2 h of uptake, with a low-density peak superimposed on the distribution of endosomes, and a high-density peak overlapping lysosomes. After an overnight chase, only the highdensity peak remained, but it could be dissociated from lysosomes, based on its refractoriness to displacement upon chloroquine-induced swelling. After 2 h of uptake at 300 nM ON-Alexa, a punctate pattern was resolved, by confocal microscopy, from those of transferrin, of a fluid-phase tracer, and of vital staining of lysosomes by LysoTracker. At 3 µM ON-Alexa, its pattern largely overlapped with the fluidphase tracer and LysoTracker. Taken together, these data suggest that ON may be internalised at low concentrations by receptor-mediated endocytosis into unique endosomes, then to dense structures that are distinct from lysosomes. The nature of these two compartments and their significance for ON effect deserve further investigation.
INTRODUCTION
Oligonucleotides (ON) are short nucleic acid sequences with a large potential for research and clinical applications; one has already been approved for medical treatment and several others are currently in clinical trials (1) . The original aim of using ON was an antisense effect (2) , whereby specific binding to a targeted (pre)mRNA by Watson-Crick base pairing would sterically inhibit translation or induce recognition and degradation by RNases (3) . However, several other ON-based approaches lead to a selective decrease in mRNA or protein content or function. They include the following: (i) ON designed to form a triple helix with a specific DNA sequence thereby blocking transcription (4); (ii) double stranded (ds) DNA decoy ON, which bind to selected transcription factors and prevent gene expression (5); (iii) RNA-ON (6) or DNA-ON (7) acting as ribozymes to directly degrade target mRNA; (iv) approaches exploiting the still poorly understood RNA interference, whereby double-stranded (ds)RNA, or fragments as small as 21 bp, can result in mRNA degradation (8) ; as a remarkable example, Escherichia coli expressing dsRNA produce specific RNA interference in the Caenorhabditis elegans larvae that feed on them (9); (v) secondary structurebased ON (aptamers) that interact either with proteins and inhibit their activity (10) or with RNA and compete for RNAbinding proteins, as is the case for the transactivation response element of HIV-1 (11) . Remarkably, ON can also have 'positive' effects, such as correction of point mutations by homologous recombination (12) or the correction of splicing errors (e.g. in thalassemia; 13).
It has long been appreciated that biological applications of ON meet with two limitations: stability and accessibility. Nonmodified ON are rapidly degraded by nucleases (14) . Capping at the 5′-end, and particularly the 3′-end, protects ON against exonucleases (7, 14) . Backbone modifications yield additional ON protection, at the risk of compromising selectivity of interactions (13) , but novel ON structures have been developed that combine improved stability and specificity (15) . The second problem is accessibility. To exert their biological effect, ON must reach the cytosol and/or the nucleus. Nuclear pores are not a diffusion barrier, since ON micro-injected in the cytosol is almost immediately transferred into the nucleus (14, 16, 17) . In contrast, the plasma membrane and the limiting membrane of endocytic organelles are impermeable to large polyanionic *To whom correspondence should be addressed. Tel: +32 2 764 75 69; Fax: +32 2 764 75 43; Email: courtoy@cell.ucl.ac.be molecules such as ON. Various physico-chemical methods (including liposome-mediated uptake, electroporation, microinjection and permeabilisation using streptolysin-O) increase cytosolic penetration and are useful for research on cultured cells (reviewed in 18), but are not practical for in vivo studies or for therapy (1, 3) .
ON are spontaneously taken up by endocytosis, which can help reach their target (reviewed in 19) . At high (micromolar) concentrations, ON are generally reported to be internalised by fluid-phase endocytosis, a process of too low efficiency to guarantee strictly specific effects (20) (21) (22) . Indeed, high concentrations lead to multiple non-specific effects, some of which are even sequence dependent (23) . In contrast, the most efficient mode of uptake of macromolecules is receptor-mediated endocytosis, whereby a plasma membrane protein binds a ligand and causes its clustering in clathrin-coated pits, resulting in accelerated internalisation. In this respect, ON was reported to bind as an 'opportunistic' ligand to the scavenger receptor in endothelial and Kupffer cells (∼100 nM) (24) or to the integrin Mac-1 in polymorphonuclear leukocytes (∼10 µM) (25) , two carriers that lead to receptor-mediated endocytosis. ON uptake can also be enhanced by the conjugation to a specific ligand, as is the case in hepatocytes after derivatisation with galactosyl moieties (26) . A variety of unidentified proteins, depending on the cell type studied, have also been suggested to act as specific 'receptors' for ON (20, 21, 27, 28) . One such ON-binding protein was found in lysates of the human HepG2 hepatoma cell line (29) , where we have recently identified, by in situ photo-affinity labelling and ligand blotting, a membrane receptor that binds ON with a K d of ∼200 nM, and for which we reported a partial amino acid sequence as a novel protein (30) .
After endocytosis, ON are sequestered in compartments of unknown nature (22, 31, 32) , from which they are thought to escape by a still elusive and presumably inefficient mechanism. The rate of ON uptake and its fate vary with backbone and end modifications. Based on relief by monensin of fluorescence quenching, fluoresceinated ON phosphorothioates were reported to occur in acidic compartments, compatible with lysosomes (the usual end-compartment of endocytic sequestration), whereas organelles accumulating fluoresceinated ON phosphodiesters appeared not or poorly acidified, indicating differential intracellular routing (31) . End modifications by signalling peptides may also reroute derivatised ON to different intracellular compartments (32) .
In the present study, we have combined kinetic studies, subcellular fractionation and confocal microscopy to analyse the endocytic properties and fate of ON phosphodiesters protected at both ends in HepG2 cell line, by focusing on the low concentrations that should ensure receptor-specific uptake.
MATERIALS AND METHODS

Tracer source and modifications
We used two derivatives of a phosphodiester 25mer ON, with sequence complementarity to the AUG initiation site of HIV-1 gag (CTCTCGCACCCATCTCTCTCCTTCT) and protected by a 3′-end phosphoro-alkylamine (Eurogentec, Seraing, Belgium) (33) . For biochemical studies, one derivative bearing a fluorescein moiety on its 5′-end was radioiodinated with IodoBeads (referred to as 125 I-ON) to a specific radioactivity of ∼9.6 × 10 16 Bq/mol (Pierce, Rockford, IL), as previously described (30, 34) . The second one, bearing a disulfide bridge on its 5′-end, was conjugated with fluorophores Alexa 488 (green signal) or Alexa 568 (red signal; both from Molecular Probes, Eugene, OR) by disulfide reduction followed by alkylation with a maleimide derivative of the fluorophore (adapted from ref. 34 , yielding a molar ratio close to the unit). Similarly, iron-saturated transferrin (Sigma, St Louis, MO) was radioiodinated using IodoBeads (to 9 × 10 14 Bq/mol), or conjugated to Alexa 568, using a Molecular Probes protein labelling kit, according to the manufacturer's instructions (with a molar ratio close to 2).
Horseradish peroxidase (HRP; type II) was from Roche Diagnostics (Brussels, Belgium). Alexa 568-labelled dextran (10 000 Da) and LysoTracker green were from Molecular Probes. Poly(C), poly(G) and poly(I), tRNA (purified from baker's yeast), ATPγ-S and GTPγ-S were from Sigma. Fraxiparine ® was from Sanofi (Paris, France). The phosphorothioate SdC-28 (a 28 homo-cytidine polymer) was from the Pasteur Institute (Paris, France), and the phosphorothioate Gem91 (with the same sequence as the 25mer phosphodiester ON used) was a kind gift from Dr S. Agrawal (Hybridon, Worcester, MA).
Tracer uptake
HepG2 cell lines were obtained from the American Type Tissue Culture Collection, or received from Dr D. Hoekstra (Groningen, The Netherlands) or Dr G. Strous (Utrecht, The Netherlands), and propagated as described (30) . For the experiments, cells were cultured in Petri dishes to near confluency (∼3 × 10 6 in a 30 cm 2 dish) and incubated in serum-free RPMI, as previously described (30) at 37°C for 1 h with either 4 mg/ ml HRP (100 µM), 5 µg/ml 125 I-transferrin (62 nM) or 1 µg/ml 125 I-fluorescein-ON (125 nM), unless otherwise specified. After uptake, dishes were transferred to 4°C and extensively washed (three times with PBS containing 0.44 mM Ca 2+ , three times with PBS-Ca 2+ supplemented with 1% BSA, and three times with PBS-Ca 2+ , for 5 min each). This washing procedure proved essential to minimise non-specific surface binding. After surface digestion by 0.1% (w/v) pronase (Sigma) in RPMI medium for 1 h, cells were harvested by centrifugation, briefly rinsed twice with PBS and lysed in 0.01% (v/v) Triton X-100. To normalise between dishes, the protein content was quantified by the bicinchoninic acid (Sigma) procedure (3 × 10 6 HepG2 cells contain ∼1 mg cell protein) (35) . HRP was assayed by a colorimetric assay using orthodianisidine (Sigma) as substrate (36) . Data analysis by non-linear regression was performed using graphpad software (www.graphpad.com).
Analytical subcellular fractionation
Cells (∼30 × 10 6 in a 175 cm 2 dish) were incubated at 37°C for 2 h in RPMI medium without serum, supplemented with 125-250 nM 125 I-ON, either alone or combined with 100 µM HRP, then washed as above. For pulse-chase experiments, cells were similarly incubated for 2 h with 125 I-ON without serum, briefly washed five times with PBS then chased for 22 h in fresh medium supplemented with 10% serum (required to sustain overnight cell viability). For density-shift experiments, cells were further treated with 100 µM chloroquine (Sigma) for the last 4 h of the chase. Cells were washed, surface-digested with pronase as above, and washed pellets were resuspended in 4 ml of the homogenisation medium SIE (0.25 M sucrose, 3 mM imidazole, 1 mM EDTA, pH 7.0).
Extraction and differential sedimentation into a low-speed pellet (the so-called nuclear fraction), a high-speed pellet (postnuclear particles) and a high-speed supernatant were performed as described (30) . Postnuclear particles were resuspended in 2 ml of SIE. One millilitre was saved for further analysis and the other was loaded on the top of a 10.5 ml linear sucrose gradient in 3 mM imidazole, 1 mM EDTA, pH 7.0, ranging from 1.10 to 1.30 g/ml in density, over a 0.5 ml cushion (1.34 g/ml in density). After centrifugation at 20 000 r.p.m. for 18 h in a SW40 rotor (Beckman, Palo Alto, CA; 55 × 10 6 g × min), 12 fractions of ∼1 ml were eluted from the bottom and their density was measured by refractometry. Cathepsin B was assayed by a fluorescent method based on the cleavage of α-N-benzoyl-DL-arginine-2-naphtylamide (Sigma) (37) . Phosphodiesterase activity was assayed by a colorimetric method based on paranitrophenylthymidylate 5′-monophosphate hydrolysis (Sigma) (38) . To compare and average density gradients, results were standardised according to Leighton et al. (39) , and presented as density/frequency histograms.
Confocal microscopy
HepG2 cells were plated at ∼3 × 10 4 cells/cm 2 and grown for 36 h in LabTek chambers (borosilicate coverglass, Nunc, Roskilde, Denmark) that were precoated with serum, rinsed for 30 min with serum-free medium and incubated at 37°C for 1-2 h with 300 nM ON-Alexa 488, followed by three washes in PBS-Ca 2+ and one wash with PBS-Ca 2+ containing 1% BSA, for 5 min each, at 4°C in the dark. To label cell contours, cells were further incubated for 1 h at 4°C in PBS-Ca 2+ containing 1% BSA and 20 µg/ml rhodamine-labelled concanavalin A (Sigma), then washed again with PBS-Ca 2+ containing 1% BSA and three times with PBS-Ca 2+ , for 5 min each. For double uptake experiments, 300 nM ON-Alexa 488 or -Alexa 568 was combined with either 80 nM transferrin-Alexa 568, 50 µM dextran-Alexa 568 or 80 nM LysoTracker green, followed by the same washing procedure. For experiments with LysoTracker, this compound was also present in washing solutions. Cells were immediately examined (without surface digestion) in their living state with an Axiovert confocal microscope (Zeiss, Oberkochen, Germany), coupled to a MRC1024 confocal scanning laser equipment (Bio-Rad, Richmond, CA).
RESULTS
Quantitative evidence for 125 I-ON receptor-mediated endocytosis in the HepG2 cell line
Two criteria for endocytosis are (i) dependence of temperature (arrest at 4°C) and (ii) acquisition of resistance to surface digestion. In order to establish a biochemical assay for receptor-dependent ON endocytosis in the HepG2 cell line, we first evaluated the possibility of removing 125 I-ON bound at 4°C to the plasma membrane, while preserving tracer internalised at 37°C. For this purpose, cells were post-treated at 4°C by pronase (40) . Incubation with 125 I-ON was performed at 125 nM, close to the K d of its putative receptor (30) and, as previously, in serum-free medium to prevent ON binding to albumin (41) . To compare modes of entry, cells were incubated in parallel with 62 nM 125 I-transferrin or 100 µM HRP, two classical tracers of receptor-mediated and fluidphase endocytosis, respectively. After uptake at 37°C for 1 h, followed by extensive washing and surface-protease digestion at 4°C, 836 ± 62 fmol 125 I-ON, 2688 ± 252 fmol 125 I-transferrin and 8375 ± 2012 fmol HRP, based on enzymatic activity (means ± SEM; n = 15, 6 and 6, respectively) were found to be associated per mg cell protein. These values were highly consistent within a given experiment but showed significant variations between experiments. Uptake was severely inhibited at 4°C for ON and HRP (>80%) and essentially abolished for transferrin (>97%). This suggested that ON or ON-receptor complexes were transferred at 37°C into a compartment resistant to surface digestion, compatible with endocytosis into intracellular structures, a conclusion directly confirmed by morphological evidence using fluorescent ON (see Fig. 6A ). The selectivity of receptor-mediated endocytosis is evidenced by the ratio of intracellular versus extracellular tracer concentrations (endocytosis uptake efficiency). After 1 h of uptake at 37°C, these ratios were ∼80-fold higher for 125 nM 125 I-ON (1.34) and 520-fold higher for 62 nM 125 I-transferrin (8.67) than for 100 µM HRP (0.017). These observations are in good agreement with the well-known efficacy of receptor-mediated endocytosis of transferrin, and are compatible with a similar mechanism operating for 125 I-ON capture into the HepG2 cell line.
The kinetics of accumulation and efflux of tracers shown at Figure 1 also reflects their mode of endocytosis. The increase of peroxidase activity (indicating HRP accumulation) was linear, as predicted for continuous filling of the late endocytic apparatus by fluid-phase endocytosis (Fig. 1C) . In contrast, accumulation of 125 I-ON (Fig. 1A) and 125 I-transferrin (Fig. 1B ) that were not released by surface pronase treatment levelled off after 1-2 h, compatible with saturation of an intracellular compartment in equilibrium with the cell surface pool. As compared with HRP uptake, the initial rate of endocytosis derived from curve fitting was 150-fold faster for ON and 1900-fold faster for transferrin. Whereas loss of peroxidase activity (indicating HRP efflux; Fig. 1F ) was slow (t ½ of 17 min) and limited (∼28% of release after 2 h of pulse), reflecting sequestration in late endosomes and lysosomes (HRP activity resists lysosomal proteolysis for several hours), the efflux of 125 I-transferrin (Fig. 1E ) was more rapid (t ½ of 10 min) and almost complete (88% of release after 2 h), as expected; the efflux of 125 I-ON (Fig. 1G ) was also rapid (t ½ of 11 min), but partial (∼45% of release after 2 h of pulse). Upon longer chase intervals, regurgitation was clearly bi-exponential (with a t ½ ∼10 h for the second component; data not shown).
Specificity of 125 I-receptor-mediated endocytosis in HepG2 cell line
Two additional hallmarks of receptor-mediated endocytosis are (i) saturation of uptake at high ligand concentration and (ii) specific competition for uptake by a large excess of the same or other ligand(s) for the same receptor, but not by non-cognate, yet structurally related compounds. When uptake was analysed at increasing 125 I-ON concentrations ( Fig. 2A) , two components could be distinguished that were better evidenced after logarithmic transformation of the endocytic uptake efficiency (Fig. 2B) . A saturable component prevailed below 1 µM and a component of lower affinity accounted for additional uptake above this concentration, both contributing equally around 1 µM. These two components are compatible with two different modes of endocytosis, namely receptor-mediated endocytosis at low ON concentrations, and non-specific endocytosis accounting for additional accumulation at high concentrations. However, the efficiency of the latter process (0.14) still exceeded by approximately one order of magnitude that of fluid-phase endocytosis (0.017; see above), thus pointing to non-specific adsorptive endocytosis.
Specificity of uptake was addressed by competition experiments (Fig. 3) . As illustrated in Figure 3A , all oligonucleotides tested efficiently competed for tracer 125 I-ON uptake: the phosphorothioate Gem91 was the strongest competitor (Ki, ∼10 nM), followed by SdC28 (a phosphorothioate homopolymer) and Poly(I) (a mixture of phosphodiester homopolymers of various length, Ki ∼30 nM for both). Poly(G) and poly(C) were 2.5-and 4.4-fold less potent (Fig. 3B) . The efficient competition by several non-modified ONs ruled out the possibility of a predominant binding of 125 I-ON via its labelling moiety. In contrast, neither the non-hydrolysable mononucleotides ATPγ-S and GTPγ-S nor the non-nucleotidic sulphated polyanion, Fraxiparine ® , a heparan sulphate fraction of comparable mass and charge to that of ON, significantly interfered with 125 I-ON uptake (Fig. 3B) . Noticeably, a mixture of tRNAs, known for their secondary structures, were good competitors up to 100 nM, but failed to further interfere with ON uptake above this concentration, suggesting that at least two classes of ON-binding proteins are involved. For control, none of these treatments significantly interfered with receptormediated endocytosis of transferrin and with fluid-phase endocytosis of peroxidase (data not shown). Thus, the receptor(s) involved appeared to recognise oligo(deoxy)ribonucleotides with a high specificity. To address the fate of ON that had been taken up at low concentrations presumably by receptor-mediated endocytosis, we next resorted to subcellular fractionation combined with confocal microscopy.
Analytical subcellular fractionation
To compare the distribution of ON that was not released by surface pronase treatment with those of endogenous marker enzymes as well as of the established endocytic tracers, 125 I-transferrin and HRP, cells were incubated with low concentrations (125-250 nM) of 125 I-ON for 2 h, with or without a 22 h chase. To further test for association with lysosomes, the equilibrium density of these organelles was shifted by a 4 h incubation in the presence of 100 µM chloroquine prior to cell collection. In preliminary experiments, 125 I-ON 
, where U is the actual uptake at a given concentration, U max HA and U max LA are saturation of uptake by high-affinity and low-affinity sites, respectively, K U HA and K U LA are corresponding half-saturation concentrations, and x is the actual extracellular concentration. To decrease the confidence interval, the K U HA value was set at 220 nM, as measured in de Diesbach et al. (30) . Deduced parameters were 0.48 pmol/mg protein for U max HA , 9.68 pmol/mg protein for U max LA and 7.5 µM for K U LA . This type of experiment was reproduced twice, yielding similar results. integrity was assessed by 15% SDS-PAGE; this analysis showed that, after surface pronase digestion, >90% of cell-associated 125 I-ON was intact after a 2 h pulse and >50% after 2 h pulse/22 h chase (data not shown). This surprisingly high fractional integrity after prolonged cell incubation provides a first indication against its retention in nuclease-rich compartments such as lysosomes.
Overall, the homogenisation procedure was (i) efficient, since ∼80% of the lysosomal marker, cathepsin B, and >90% of the plasma/endosomal membranes marker, alkaline phosphodiesterase I, were extracted in the post-nuclear supernatant; and (ii) not harmful, since 70-90% of the extracted markers were sedimentable in the high-speed pellet, which amounted to ∼40% of total cell protein. Upon chloroquine treatment, cellassociated cathepsin B activity was decreased by 3.2 ± 0.7-fold (mean ± SD; n = 3), in good agreement with the literature (42) . A higher and variable proportion of total cell cathepsin B was recovered in the high-speed supernatant, reflecting vulnerability of swollen lysosomes. At the opposite of the cathepsin B content, the ON accumulation was not appreciably altered by chloroquine (105% of control; n = 2). About one-third of ON remained in the low-speed pellet and about two-thirds of extracted ON was sedimentable in the post-nuclear particles, both in untreated and chloroquine-treated cells. Unequal sedimentability of cathepsin B and ON in the post-nuclear supernatants of individual fractionation experiments provided a second argument against a major association of ON with lysosomes. To exclude a nuclear relocation artefacts due to release from broken organelles and selective uptake by the nuclei (16,17) , a homogenate of naive, pronase-treated cells was incubated at 4°C for 1 h with 125 I-ON before the fractionation procedure; 97% of the ON was found in the high-speed supernatant (cytosolic) fraction and only 1% in the low-speed pellet (nuclear) fraction. This in vitro mixing experiment excludes the fact that ON occurring in the low-speed pellet would result from artificial nuclear transfer after homogenisation. However, it does not allow the conclusion that the ON occurring in the low-speed pellet after ON endocytosis necessarily reflects genuine nuclear location.
Next, post-nuclear particles were analysed by equilibration after top loading on linear sucrose gradients (Fig. 4) . After 2 h of uptake, the density distribution of 125 I-ON was bimodal, with a low-density peak at 1.12 g/ml and a high-density peak of comparable size at 1.21 g/ml (Fig. 4A) , and clearly distinct from the overall protein distribution (Fig. 4D) . To further exclude 125 I-ON re-absorption to organelle membranes, a postnuclear pellet obtained from naive cells was again mixed in vitro with 125 I-ON and equilibrated in parallel: all radioactivity remained in the loading zone, at the top of the gradient. In a second control, postnuclear particles of cells incubated with 125 I-ON were loaded below the gradient and allowed to float into the gradient: the same bimodal pattern, with identical density peaks, was observed as after loading on the top of the gradient, demonstrating that equilibrium density was reached in both cases (data not shown). In contrast to ON, HRP taken up by the same cells showed a clearly unimodal peak of activity at 1.12 g/ml (Fig. 4B ), closely coinciding with the plasma/endosomal membranes marker, alkaline phosphodiesterase I (Fig. 4C) , and with the low-density peak of ON. The high-density peak of ON partially overlapped with that of the lysosomal marker, cathepsin B (see Fig. 5B ). This analysis was thus compatible with a dual localisation of 125 I-ON, partially endosomal and partially dense, possibly in a lysosomal subset.
To further test for lysosomal accessibility, 125 I-ON and HRP accumulation were followed by an overnight chase, to allow both tracers to progress along the endocytic apparatus (Fig. 5A ). This extended chase decreased the cell ON content by~90% (see above). The density distribution of the cellassociated radioactivity became essentially restricted to its dense component (1.19 g/ml; Fig. 5A ) and largely overlapped the cathepsin B peak (1.18 g/ml; Fig. 5B , thin line), like peroxidase activity (Fig. 5C, thin line) .
To directly address whether ON had actually reached lysosomes, cells were treated with chloroquine. This amphiphilic weak-base passes through biological membranes in its nonprotonated form and becomes charged and trapped in closed acidified compartments (43) . It is well established that acidotropic accumulation of chloroquine leads to a considerable concentration of the drug in lysosomes, in proportion to their transmembrane pH gradient. The resulting osmotic swelling of lysosomes provokes a selective shift of their equilibrium density (44) . Whereas, upon chloroquine treatment, distributions of both the endogenous lysosomal marker, cathepsin B, and the exogenous tracer, HRP, having accumulated in lysosomes after a long chase, were clearly displaced towards lighter densities (Fig. 5A) , thus being clearly resolved from the two lysosomal constituents. This dissociation strongly suggests that 125 I-ON internalised at low concentrations does not become appreciably associated with lysosomes. The resistance to chloroquine-induced displacement further indicates that the compartment containing phosphodiester ON is not actively acidified.
Confocal microscopy
We next attempted to localise, by confocal microscopy in living cells, fluorescent ON that had been taken up at concentrations relevant to study a receptor-mediated process. Although at 3 µM fluorescein-labelled ON was clearly evidenced in punctate intracellular structures, no signal was detected at 300 nM. Since it was uncertain whether the former signal reflected receptor-mediated endocytosis (see above), two other conjugates were prepared to exploit the higher fluorescence quantum yield of Alexa probes. Using these compounds, a detectable signal was clearly observed in discrete structures after ≥15 min incubation with 300 nM ON, when conjugated to either Alexa 488 (green) or Alexa 568 (red). Since these structures were frequently found near to the cell periphery, it was necessary for assessing endocytosis to delineate cell contours, for which we resorted to subsequent plasma membrane labelling at 4°C with a fluorescent lectin, rhodamine-labelled concanavalin A (Fig. 6A, red) . This double labelling procedure demonstrated intracellular localisation of ON-Alexa 488. The specificity of uptake of ON-Alexa 488 was established, upon competition by a 100-fold excess of Gem91, by its complete disappearance at the appropriate confocal setting (Fig. 6B) . This setting was thus selected for, and repeatedly validated by, subsequent experiments. The nature of the intracellular ON compartment was analysed by reference to endosomes, labelled upon receptor-mediated endocytosis of fluorescent transferrin, and to lysosomes, labelled by LysoTracker, a fluorescent acidotropic tracer that accumulates in lysosomes similarly to chloroquine. The specificity of the detection of transferrin-Alexa 568, after uptake by receptor-mediated endocytosis at 80 nM, was established by the total disappearance of intracellular signal upon competition with a 200-fold molar excess of unlabelled transferrin (Fig. 6D) . High transferrin concentration did not detectably affect ON uptake (persistence of green signal in Fig. 6D ), nor did high ON concentration affect intracellular transferrin signal (data not shown). Upon simultaneous incubation with 300 nM ON-Alexa 488 (green) and 80 nM transferrin-Alexa 568 (red) for 15 min (data not shown) or 2 h (Fig. 6C) , transferrin appeared to reach multiple organelles dispersed among the entire cell cytoplasm, whereas ON remained predominantly in a peripheral cytoplasmic location. When both signals were merged, no co-localisation was detected (Fig. 6C) , pointing to distinct endocytic pathways and, possibly, mechanisms. As stated above, intracellular labelling of fluorescent ON reported in the literature had been obtained at higher concentrations (up to 7.5 µM) (23,31,32,45 ) that could reflect, at least in part, fluid-phase endocytosis. It was, therefore, essential to examine whether the intracellular route of ON would be different, depending on the mode of entry. Indeed, fluid-phase and adsorptive endocytic tracers become generally trapped in lysosomes whereas receptor-bound tracers may be targeted to various distinct compartments. For this purpose, we followed the fate of ON-Alexa 488 at 300 nM (to track receptor-mediated endocytosis), or at 3 µM (to also follow non-specific endocytosis); the ON signal was further compared with that of a fluorescent dextran, a well-established tracer of fluid-phase endocytosis (46) . After 1 h of uptake at 300 nM, ON-Alexa 488 (green) was completely separated from dextran-Alexa 568 (Fig. 6E, red) , but some co-localisation was evident at 3 µM ON-Alexa 488 (Fig. 6F, arrows) .
Dissociation of the ON compartment from lysosomes was also tested by confocal microscopy, using lysosomal vital staining by LysoTracker green. The high acidotropic concentration of this compound, endowed with a low intrinsic fluorescence, generates a fluorescent signal specifically in these organelles (47) . As expected, LysoTracker green essentially produced a perinuclear punctate pattern. When cells were incubated simultaneously with 300 nM ON-Alexa 568 (red) and LysoTracker (green), no co-localisation was detected between these two probes (Fig. 6G) , whereas some co-localisation could be detected at 3 µM ON-Alexa 568 (Fig. 6H) .
DISCUSSION
In this paper, we show that phosphodiester oligonucleotides, when taken up by the HepG2 cell line at low concentrations, are internalised by receptor-mediated endocytosis, transferred into low-density organelles that are distinct from transferrincontaining endosomes and stored in dense organelles that are distinct from lysosomes.
When applied at a concentration close to the K d of the 66 kDa receptor recently identified by in situ photo-affinity labelling in the same cell line, the endocytic behaviour of ON completely differs from that of the fluid-phase tracer, HRP, and resembles that of the receptor-mediated endocytic tracer, transferrin. The initial clearance rate of 125 I-ON internalisation is ∼2 log higher than for HRP, excluding fluid-phase endocytosis, but is similar to that of transferrin, which is internalised via clathrin-coated pits. Moreover, the endocytic constant (i.e. the ratio of intracellular over surface-bound values) (48) , which best describes the rate of internalisation of membraneassociated constituents, can be estimated on the basis of the initial slope at 7% × min -1 for ON, as compared with 18% × min -1 for transferrin. Since transferrin receptors are concentrated ∼10-fold in clathrin-coated pits (49) , this suggests that ON-receptor complexes can also be concentrated, ∼4-fold, in these structures. Overall, the hyperbolic internalisation kinetics and the considerable release of ON also completely differ from the linear accumulation and marginal release of the fluid-phase tracer, HRP, and resemble those of transferrin. This suggests that a large fraction of ON/receptor complexes would rapidly recycle to the cell surface, together with ligands released into the extracellular medium, and that the plateau of uptake would reflect saturation of the specific cell endocytic machinery, when all accessible compartments containing cycling receptors have been reached (45) .
Upon increasing ON concentration, surface receptors become saturated. Non-linear curve fitting allows one to distinguish two components: a saturable, high-affinity component, and an almost linear component above 1 µM. The endocytic efficiency of this linear component is, however, 10-fold higher than accounted for by fluid-phase endocytosis and therefore implies adsorptive non-specific endocytosis. At variance, the efficacy of ON endocytosis above 1 µM in L929 mouse fibroblast and in K562 human leukemia cell lines has been reported to be comparable with those of polyvinyl-pyrrolidone or sucrose, used to follow fluid-phase endocytosis (20, 21) . However, the endocytic uptake efficiency calculated from these two reports was much higher (>30-fold) than for HRP endocytosis in our experimental system. This discrepancy may be related, among other factors, to the difficulty in achieving complete removal of extracellular fluid-phase tracers by washing alone, which can be circumvented by cell surface digestion as used in the present study.
After 125 I-ON exposure at 4°C, protease treatment of washed cells releases ∼90% of cell-associated radioactivity, while this value falls to ∼50% after 1 h incubation at 37°C. Since it was ascertained that the integrity of ON was unaffected by the pronase solution, excluding significant contamination by a nuclease, the almost complete release of surface-bound ON after uptake at 4°C strongly suggests that ON receptors leading to efficient ON internalisation are proteic in nature. Partial resistance to pronase digestion after incubation at 37°C has been reported by other investigators (40) and indicates transfer of surface-bound ON to intracellular organelles. This was directly demonstrated by confocal microscopy.
The nature of ON receptors in the HepG2 cell line has been previously addressed by using in situ photo-affinity labelling of intact cells, as well as ligand blotting of cell lysates (30) . Among various ON-binding bands, one protein candidate was singled out as an ON endocytic membrane receptor, based on its resistance to carbonate extraction and its partial sensitivity to cell-surface pronase digestion. By in situ photo-affinity labelling and ligand blotting, 125 I-ON binding was sensitive to competition by ON (C. Berens, unpublished results), but not by non-nucleotidic polyanions, arguing against non-specific electrostatic interaction (20, 27) . In the present report, a polysulphated polymer of comparable size (the small molecular weight heparin fragments, Fraxiparine ® ) failed to compete with the interaction. In contrast, all oligo-and polynucleotides tested, irrespective of the sugar residue and of the backbone (PO versus PS), were effective competitors indicating that we were dealing with an oligo-or polynucleotide receptor. The occurrence of a membrane receptor that recognises tRNA may be related to the recent demonstration of its transfer across the mitochondrial membrane in mammalian cells (50) .
The nature of the ON-containing compartments was addressed by kinetic, fractionation and confocal studies. The existence of two components is indicated by a biphasic efflux kinetic (31) , and by a bimodal distribution after subcellular fractionation. Available information does not allow the exclusion of a model involving two parallel pathways of different kinetics (i.e., a compartment rapidly accessible to endocytosis and recycling, corresponding to the low-density peak, and an unrelated slowly accessible compartment, corresponding to the high-density peak). However, a sequential model is more in agreement with the general knowledge of the endocytic apparatus.
Neither of these compartments appears to be actively acidified since ON internalised for up to 6 h failed to co-localise with LysoTracker by confocal microscopy and, after an overnight chase, failed to be shifted by chloroquine, in contrast to the lysosomal marker, cathepsin B, and the sequestered fluidphase endocytic tracer, HRP. This contrasts with the acidification of phosphorothioate ON-containing compartment (31) , indicating that the cargo could modify the fate of the ON receptor. These results are apparently in agreement with the reported absence of relief by monensin of acidic fluorescence quenching of fluoresceinated PO-ON internalised at micromolar concentrations in intact cells (31) . However, when using the same micromolar concentrations, we found that some ON was clearly associated in LysoTracker-labelled structures located deep in the cell. Nevertheless, the bulk of ON remained at the cell periphery in structures devoid of detectable LysoTracker labelling. Such a heterogeneity emphasizes the complementary value of morphological approaches.
The identification of the two intracellular compartments involved in phosphodiester ON trafficking after incubation at sub-micromolar concentrations remains unclear and could in principle be addressed by immunolocalisation in confocal microscopy. However, contrary to ON derivatised with lysinecontaining peptides (32), we found that ON used in this study were poorly cross-linked by aldehyde fixatives and serious artefacts in their localisation after non-aldehyde-based fixation have been reported (51) . Although working on living cells is not very practical, because of the rapid ON efflux, this approach appears more reliable but precludes comparison with the immunolocalisation pattern of organelle markers.
As a final word of caution, it should be stressed that results reported in this paper on the uptake and subcellular fate of ON deal with an established cell line and an end-protected phophodiester ON. Whether they are applicable to other established cell lines, to cells in primary culture, or in living animals, and their relevance to other types of ON await to be ascertained. First, gene expression in established cell lines frequently differs from their in situ counterpart and their pattern is subject to drift with time. Cryptic viral or mycoplasma contamination, which could alter cellular uptake and intracellular routing, is also hard to totally exclude. Second, phosphorothioate ON, which are usually better inhibitors of gene expression than phosphodiesters, may interact with other receptors and/or follow other intracellular routes (31) . Third, the peculiar endocytotic properties described in this report do not address the passage of ON across a membrane into the cytosolic compartment. Further investigations addressing these specific issues and concerns are clearly warranted.
